Aflatoxin-DNA adducts as biomarkers of cancer: Nature, formation, kinds of AF-DNA adducts, methodology, effects, and control

ACS Symposium Series

Volumn 1001, Issue , 2008, Pages 13-55

  Carvajal, Magda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXINS; AMINO ACIDS; ANIMALS; BIOMARKERS; CHROMATOGRAPHY; DISEASES; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELLAGIC ACID; ENZYME INHIBITION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; MOLECULAR BIOLOGY; MONOCLONAL ANTIBODIES; NUTRITION; PHYSIOLOGY; PLANTS (BOTANY); POSITIVE IONS; RECOMBINANT PROTEINS; RISK ASSESSMENT; SELENIUM COMPOUNDS; TOXICITY;

BIOLOGICALLY EFFECTIVE DOSE; CYTOCHROME P450 MONOOXYGENASES; ENZYME LINKED IMMUNOSORBENT ASSAY; INDIRECT IMMUNOFLUORESCENCE; LIQUID CHROMATOGRAPHY ELECTROSPRAY; NORDIHYDROGUAIARETIC ACID; P53 TUMOR SUPPRESSOR GENES; PRIMARY HEPATOCELLULAR CARCINOMA;

DNA;

EID: 84872585634     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2008-1001.ch002     Document Type: Conference Paper

References (133)

1. Asao, T.; Buchi, G.; Abdel-Kader, M. M.; Chang, S. B.; Wick, E. L.; Wogan, G. N. Aflatoxins B and G. J. Amer. Chem. Soc. 1963, 85, 1706-1707.
2. Butler, W. H. Aflatoxins. In Mycotoxins; Purchase, I. F. H., Ed; Elsevier: Amsterdam, 1974; pp 1-28.
3. Chang, S. B.; Abdel-Kader, M. M.; Wick, E. L.; Wogan, G. N. Aflatoxin B2 : Chemical identity and biological activity. Science 1963, 142, 1191-1192.
4. Harrison, J. C.; Carvajal, M.; Garner, R. C. Does AF exposure in the United Kingdom constitute a cancer risk? Environ. Health Perspect. 1993, 99, 99-105.
5. Bronson, R.; Birt, D.; Meydani, S. N. Biomarkers as early predictors of long-Term health status and human immune function. Nutr. Rev. 1999, 57, S7-S12.
6. Wright, A. S.; Bradshaw, T. K.; Watson, W. P. In Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention; IARC Scientific Publications No. 89. Bartsch, H.; Hemminki, K.; O'Neill, I. K. Eds.; International Agency for Research on Cancer: Lyon, France, 1988; pp 237-247.
7. Ames, B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983, 221, 1256-1264.
8. Kasai, H.; Nishimura, S. Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents. Environ. Health Perspect. 1986, 67, 111-116.
9. Hsieh, L. L., Hsu, S. W., Chen, D. S., Santella, R. M. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res. 1988, 48, 6328-6331.
10. Wild, C. P.; Pisani, P. Carcinogen DNA and protein adducts as biomarkers of human exposure in environmental cancer epidemiology. Cancer Detect. Prev. 1998, 22, 273-283.
11. Yu, M. W.; Lien, J. P.; Liaw, Y. F.; Chen, C. J. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Cancer Epidemiol. Biomark. Prev. 1996, 5, 613-619.
12. Chelcheleh, M.; Allameh, A. In vivo biotransformation of aflatoxin B1 and its interaction with cellular macromolecules in neonatal rats. Mech. Ageing Dev. 1995, 78, 189-196.
13. Shupe, T.; Sell, S. Low hepatic glutathione S-Transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice. Toxicol. Lett. 2004, 148, 1-9.
14. Larsson, P.; Tjalve, H. Extrahepatic bioactivation of aflatoxin B1 in fetal, infant and adult rats. Chem. Biol. Interact. 1995, 94, 1-19.
15. Jennings, G. S.; Oesch, F.; Steinberg, P. In vivo formation of aflatoxin B1-DNA adducts in parenchymal and non-parenchymal cells of rat liver. Carcinogenesis 1992, 13, 831-835.
16. Donnelly, P. J.; Stewart, R. K.; Ali, S. L.; Conlan, A. A.; Reid, K. R.; Petsikas, D.; Massey, T. E. Biotransformation of aflatoxin B1 in human lung. Carcinogenesis 1996, 17,2487-2494.
17. Salbe, A. D.; Bjeldanes, L. F. Effect of diet and route of administration on the DNA binding of aflatoxin B1 in the rat. Carcinogenesis 1989, 10, 629-634.
18. Kolars, J. C.; Benedict, P.; Schmiedlin-Ren, P.; Watkins, P. B. Aflatoxin B1-Adduct formation in rat and human small bowel enterocytes. Gastroenterology 1994, 106, 433-439.
19. Coulombe, R. A. Jr.; Wilson, D. W.; Hsieh, D. P.; Plopper, C. G.; Serabjit-Singh, C. J. Metabolism of aflatoxin B1 in the upper airways of the rabbit: role of the non-ciliated tracheal epithelial cell. Cancer Res. 1986, 46, 4091-4096.
20. Hsieh, L. L.; Hsieh, T. T. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer Res. 1993, 53, 1278-1280.
21. Carpenter, H. M.; Zhang, Q.; el Zahr, C.; Selivonchick, D. P.; Brock, D. E.; Curtis, L. R. In vitro and in vivo temperature modulation of hepatic metabolism and DNA adduction of aflatoxin B1 in rainbow trout. J. Biochem. Toxicol. 1995, 10, 1-10.
22. Zhang, Q.; Suorsa-Super, K.; Curtis, L. R. Temperature-modulated aflatoxin B1 hepatic disposition and formation and persistence of DNA adducts in rainbow trout. Toxicol. Appl. Pharmacol. 1992, 113, 253-259.
23. Bailey, G. S.; Loveland, P. M.; Pereira, C.; Pierce, D.; Hendricks, J. D.; Groopman, J. D. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct. Mutat. Res. 1994, 313, 25-38.
24. Croy, R. G.; Nixon, J. E.; Sinnhuber, R. O.; Wogan, G. N. Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liver. Carcinogenesis 1980, 1, 903-909.
25. Buss, P.; Caviezel, M.; Lutz, W. K. Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to AFB1 . Carcinogenesis 1990, 11, 2133-2135.
26. Jacobsen, J. S.; Refolo, L. M.; Conley, M. P.; Sambamurti, K.; Humayun, M. Z. DNA replication-blocking properties of adducts formed by aflatoxin B1-2,3-dichloride and aflatoxin B1-2,3-oxide. Mutat Res. 1987, 179, 89-101.
27. Ross, M. K.; Said, B.; Shank, R. C. DNA-damaging effects of genotoxins in mixture: modulation of covalent binding to DNA. Toxicol, Sci. 2000, 53, 224-236.
28. Irvin, T. R.; Wogan, G. N. Quantitation of AFB1 adduction within the ribosomal RNA gene sequences of rat liver DNA. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 664-668.
29. Swenson, D. H.; Lin, J. K.; Miller, E. C.; Miller, J. A. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res. 1977, 37, 172-181.
30. Troxel, C. M.; Buhler, D. R.; Hendricks, J. D.; Bailey, G. S. CYP1A induction by β-naphthoflavone, Aroclor 1254 and 2,3,7,8-Tetrachlorodibenzo- p-dioxin and its influence on aflaxtoxin B1 metabolism and DNA adduction in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 1997, 146, 69-78.
31. Troxel, C. M.; Reddy, A. P.; O'Neal, P. E.; Hendricks, J. D.; Bailey, G. S. In vivo aflatoxin B1 metabolism and hepatic DNA adduction in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 1997, 143, 213-220.
32. Denissenko, M. F.; Cahill, J.; Koudriakova, T. B.; Gerber, N.; Pfeifer, G. P. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems. Mutat. Res. 1999, 425, 205-211.
33. Lee, H. S.; Sarosi, I.; Vyas, G. N. Aflatoxin B1 formamido pyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology 1989, 97, 1281-1287.
34. Yu, M. W.; Chiang, Y. C.; Lien, J. P.; Chen, C. J. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males. Carcinogenesis 1997, 18, 1189-1194.
35. Ball, R. W.; Wilson, D. W.; Coulombe, R. A. Jr. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium. Cancer Res. 1990, 50, 4918-4922.
36. Choi, M. J.; Lee, J. W.; Lee, B. M. Comparative assessment of DNA adduct formation, Salmonella mutagenicity, and chromosome aberration assays as short-Term tests for DNA damage. J. Toxicol. Environ. Health. 1996, 49, 271-284.
37. Sotomayor, R. E.; Sahu, S.; Washington, M.; Hinton, D. M.; Chou, M. Temporal patterns of DNA adduct formation and glutathione S-Transferase activity in the testes of rats fed aflatoxin B1: A comparison with patterns in the liver. Environ. Mol. Mutagen. 1999, 33, 293-302.
38. Towner, R. A.; Qian, S. Y.; Kadiiska, M. B.; Mason, R. P. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Radic. Biol. Med. 2003, 35, 1330-1340.
39. Mace, K.; Aguilar, F.; Wang, J. S.; Vautravers, P.; Gomez-Lechon, M.; Gonzalez, F. J.; Groopman, J.; Harris, C. C.; Pfeifer, A. M. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis 1997, 18, 1291-1297.
40. Kimura, M.; Lehmann, K.; Gopalan-Kriczky, P.; Lotlikar, P. D. Effect of diet on aflatoxin B1-induced glutathione S-Transferase placental form positive hepatic foci in the rat. Exp. Mol. Med. 2004, 36, 351-357.
41. Hasler, J. A.; Dube, N.; Nyathi, C. B.; Fuhrmann, H.; Sallmann, H. P. The influence of dietary fat on hepatic bioactivation of aflatoxin B1 in rats. Res. Commun. Chem. Pathol. Pharmacol. 1994, 83, 279-287.
42. Schrager, T. F.; Newberne, P. M.; Pikul, A. H.; Groopman, J. D. Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet. Carcinogenesis 1990, 11, 177-180.
43. Chou, M. W.; Chen, W. Food restriction reduces Aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation and DNA damage in AFB1-Treated male F344 rats and B6C3F1 mice. J. Nutr. 1997, 127, 210-217.
44. Chou, M. W.; Shaddock, J. G.; Kong, J.; Hart, R. W.; Casciano, D. A. Effect of dietary restriction on partial hepatectomy-induced liver regeneration of aged F344 rats. Cancer Lett. 1995, 91, 191-197.
45. Gao, P.; Chou, M. W. Effect of caloric restriction on hepatic nuclear DNA damage in male Fischer 344 rats treated with aflatoxin B1 . Toxicol. Lett. 1992, 61, 233-242.
46. Liu, L.; Massey, T. E. Bioactivation of aflatoxin B1 by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guineapig tissues. Carcinogenesis 1992, 13, 533-539.
47. Wang, H.; Dick, R.; Yin, H.; Licad-Coles, E.; Kroetz, D. L.; Szklarz, G.; Harlow, G.; Halpert, J. R.; Correia, M. A. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe. Biochemistry 1998, 37, 12536-12545.
48. Yang, Y. H.; Miranda, C. L.; Henderson, M. C.; Wang-Buhler, J. L.; Buhler, D. R. Heterologous expression of Cyp2k1 and identification of the expressed protein (bv-Cyp2k1) as lauric acid (ω-1)-hydroxylase and aflatoxin B1 exo-epoxidase. Drug Metab. Dispos. 2000, 28, 1279-1283.
49. Guengerich, F. P.; Johnson, W. W.; Ueng, Y. F.; Yamazaki, H.; Shimada, T. Involvement of cytochrome P 450, glutathione S-Transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect. 1996, 104, 557-562.
50. Faletto, M. B.; Koser, P. L.; Battula, N.; Townsend, G. K.; Maccubbin, A. E.; Gelboin, H. V.; Gurtoo, H. L. Cytochrome P3450 cDNA encodes AFB1-4-hydroxylase. J. Biol. Chem. 1988, 263, 12187-12189.
51. Knight, L. P.; Primiano, T.; Groopman, J. D.; Kensler, T. W.; Sutter, T. R. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis 1999, 20, 1215-1223.
52. Wojnowski, L.; Turner, P. C.; Pedersen, B.; Hustert, E.; Brockmoller, J.; Mendy, M.; Whittle, H. C.; Kirk, G.; Wild, C. P. Increased levels of aflatoxin-Albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics 2004, 14, 691-700.
53. Hsieh, D. P.; Atkinson, D. N. Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of association. Food Addit. Contam. 1995, 12, 421-424.
54. Guengerich, F. P.; Shimada, T.; Raney, K. D.; Kim, D. H.; Baertschi, S. W.; Harris, T. M. Bioactivation of aflatoxins and sterigmatocystin by human liver cytochrome P-450 enzymes. In Mycotoxins, Cancer, and Health; Bray, G. A.; Ryan, D. H., Eds.; Louisiana State University Press: Baton Rouge, LA, 1991; 153-163.
55. Zarba, A.; Hmieleski, R.; Hemenway, D. R.; Jakab, G. J.; Groopman, J. D. Aflatoxin B1 -DNA adduct formation in rat liver following exposure by aerosol inhalation. Carcinogenesis 1992, 13, 1031-1033.
56. Biswas, G.; Raj, H. G.; Allameh, A.; Saxena, M.; Srivastava, N.; Mukerji, K. G. Comparative kinetic studies on aflatoxin B1 binding to pulmonary and hepatic DNA of rat and hamster receiving the carcinogen intratracheally. Teratog. Carcinog. Mutagen. 1993, 13, 259-268.
57. Putt, D. A.; Ding, X.; Coon, M. J.; Hollenberg, P. F. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11. Carcinogenesis 1995, 16, 1411-1417.
58. Gradelet, S.; Le Bon, A. M.; Berges, R.; Suschetet, M.; Astorg, P. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis 1998, 19, 403-411.
59. Essigmann, J. M.; Croy, R. G.; Nadzan, A. M.; Busby, W. F. Jr.; Reinhold, V. N.; Buchi, G.; Wogan, G. N. Structural Identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 1870-1874.
60. Lin, J. K.; Miller, J. A.; Miller, E. C. 2,3-Dihydro-2-(guan-7-yl)-3- hydroxy-Aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977, 37, 4430-4438.
61. Martin, C. N.; Garner, R. C. Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature 1977, 26, 863-865.
62. Fennell, T. R.; MacNeela, J. P.; Turner, M. J.; Swenberg, J. A. Hemoglobin adduct formation by acrylonitrile in rats and mice. In Human Carcinogen Exposure. Biomonitoring and Risk Assessment, Garner, R. C.; Farmer, P. B.; Steel, G. T.; Wright, A. S., Eds.; IRL Oxford University Press: Oxford, UK, 1991; pp 241-246.
63. Autrup, H.; Seremet, T.; Sherson, D. Quantitation of polycyclic aromatic hydrocarbon-serum protein and lymphocyte DNA adducts in Danish foundry workers using immunoassays. In Human Carcinogen Exposure. Biomonitoring and Risk Assessment; Garner, R. C.; Farmer, P. B.; Steel, G. T.; Wright, A. S., eds.; IRL Press, Oxford University Press: Oxford, UK. 1991; pp 207-214.
64. Benasutti, M.; Ejadi, S.; Whitlow, M. D.; Loechler, E. L. Mapping the binding site of aflatoxin B1 in DNA: Systematic analysis of the reactivity of aflatoxin th guanines in different DNA sequences. Biochemistry 1988, 27, 472-481.
65. Shaulsky, G.; Johnson, R. L.; Shockcor, J. P.; Taylor, L. C. E.; Stark, A. A. Properties of aflatoxin -DNA adducts formed by photoactivation and characterization of the major photoadduct as aflatoxin-N7-guanine. Carcinogenesis 1990, 11, 519-527.
66. Baertschi, S. W.; Raney, K. D.; Shimada,T.; Harris, T. M.; Guengerich, F. F. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1 and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses. Chem. Res. Toxicol. 1989, 2, 114-122.
67. Gopalakrishnan, S.; Harris, T. M.; Stone, M. P. Intercalation of aflatoxin B1 in two oligodeoxynucleotide adducts: comparative 1H NMR analysis of d(ATCAFBGAT), d(ATCGAT) and d(ATAFBGCAT)2. Biochemistry 1990, 29, 10438-10448.
68. Autrup, H.; Wakhisi, J. Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. IARC Scientific Publications No. 89. Bartsch, H.; Hemminki, K.; O'Neill, I. K., eds.; International Agency for Research on Cancer: Lyon, France, 1988; pp 63-66.
69. Donahue, P. L.; Essigman, J. M.; Wogan, G. N. Aflatoxin-DNA adducts: Detection in urine as a dosimeter of exposure. In Banbury Report 13: Indicators of Genotoxic Exposure;. Bridges, B. A.; Butterworth, B. E.; Weinstein, I. B., Eds.; Cold Spring Harbor Laboratory, Cold Spring Harbor: New York, NY, 1982; 221-229.
70. Croy R. G.; Wogan, G. N. Identification of an AFP1-DNA adduct formed in vivo in rat liver. Proc. Amer. Assoc. Cancer Res. 1979, 20, 182.
71. Schoenhard, G. L.; Hendricks, J. D.; Nixon, J. E.; Lee, D. J.; Wales, J. H.; Sinnhuber, R. O.; Pawlowski, N. E. Aflatoxicol-induced hepatocellular carcinoma in rainbow trout (Salmo gairdneri) and the synergistic effects of cyclopropenoid fatty acids. Cancer Res. 1981, 41, 1011-1014.
72. Loveland, P. M.; Nixon, J. E.; Pawlowski, N. E.; Eisele, T. A.; Libbey, L. M.; Sinnhuber, R. O. Aflatoxin B1 and aflatoxicol metabolism in rainbow trout (Salmo gairdneri) and the effects of dietary cyclopropene. J. Environ. Pathol. Toxicol. 1979, 2, 707-718.
73. Mahoney, E. M.; Ballm, J. C.; Swenson, D. H.; Richmond, D.; Maher, V. M.; McCormick, J. J. Cytotoxicity and mutagenicity of AF dichloride in normal and repair deficient diploid human fibroblasts. Chem. Biol. Interact. 1984, 50, 59-76.
74. Croy, R. G.; Wogan, G. N. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res. 1981, 41, 197-203.
75. Dashwood, R. H.; Marien, K.; Loveland, P. M.; Williams, D. E.; Hendricks, J. D.; Bailey, G. S. Formation of AF-DNA adducts in trout and their use as molecular dosimeters for tumour prediction. In Handbook of Applied Mycology. Volume 5: Mycotoxins in Ecological Systems; Marcel Dekker, Inc.: New York, NY, 1992; 183-211.
76. Osterman-Golkar, S.; Ehrenberg, L.; Segerback, D.; Hallstrom, I. Evaluation of the genetic risks of alkylating agents. Mutat. Res. 1976, 34, 1.
77. Segerback, D.; Calleman, C. J.; Ehrenberg, L.; Lofroth, G.; Osterman-Golkar, S. Evaluation of genetic risks of alkylating agents. IV Quantitative determination of alkylating aminoacids in hemoglobin as measure of the dose after treatment of mice with methyl methanesulfonate. Mutat. Res. 1978, 49, 71-82.
78. Turner, P. C.; Dingley, K. H.; Coxhead, J.; Russell, S.; Garner, C. R. Detectable levels of serum AF B1-Albumin adducts in the United Kingdom population: implications for AF-B1 exposure in the United Kingdom. Cancer Epidemiol. Biomark. Prev. 1998, 7, 441-447.
79. Wang, J. S.; Abubaker, S.; He, X.; Sun, G.; Strickland, P. T.; Groopman, J. D. Development of aflatoxin B1-lysine adduct monoclonal Antibody for human exposure studies. Appl Environ. Microbiol. 2001, 67, 2712-2717.
80. Wild, C. P.; Hasegawa, R.; Barraud, L.; Chutimataewin, S.; Chapot, B.; Ito, N.; Montesano, R. Aflatoxin-Albumin adducts: a basis for comparative carcinogenesis between animals and humans. Cancer Epidemiol. Biomark. Prev. 1996, 5, 179-189.
81. Anwar, W. A.; Khalil, M. M.; Wild, C. P. Micronuclei, chromosomal aberrations and AF-Albumin adducts in experimental animals after exposure to aflatoxin B1. Mutat Res. 1994, 322, 61-67.
82. D'Andrea, A. D.; Haseltine, W. A. Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 4120-4124.
83. Yu, F. L.; Huang, J. X.; Bender, W.; Wu, Z.; Chang, J. C. S. Evidence for the covalent binding of aflatoxin B1-dichloride to cytosine in DNA. Carcinogenesis 1991, 12, 997-1002.
84. Harrison, J. C.; Carvajal, M.; Garner, R. C. Immunological detection of aflatoxin B1-DNA and aflatoxin B1-serum albumin adducts in rat and human tissues. In: Human Carcinogen Exposure: Biomonitoring and Risk Assessment; IRL Press, Oxford University Press: Oxford, UK, 1991; 255-265.
85. Sotomayor, R. E.; Washington, M.; Nguyen, L.; Nyang'anyi, R.; Hinton, D. M.; Chou, M. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns. Toxicol Sci. 2003, 73, 329-338.
86. Walton, M.; Egner, P.; Scholl, P. F.; Walker, J.; Kensler, T. W.; Groopman, J. D. Liquid chromatography electrospray-mass spectrometry of urinary AF biomarkers: characterization and application to dosimetry and chemoprevention in rats. Chem. Res. Toxicol 2001, 14, 919-926.
87. Groopman, J. D.; Trudel, L. J.; Donahue, P. R.; Marshak-Rothstein, A.; Wogan, G. N. High-Affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 7728-7731.
88. Groopman, J. D.; Roebuck, B. D.; Kensler, T. W. Application of monoclonal antibodies and dietary antioxidant-based animal models to define human exposure to AFB1. Progr. Exp.Tumor Res. 1987, 31, 52-62.
89. Groopman, J. D.; Kensler, T. W. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1. Pharmacol. Ther. 1987, 34, 321-334
90. Pestka, J. J.; Li, Y. K.; Chu, F. S. Reactivity of aflatoxin B2a antibody with aflatoxin B1-modifled DNA and related metabolites. Appl. Environ. Microbiol. 1982, 44, 1159-1165.
91. Garner, R. C.; Dvořačkova, I.; Tursi, F. Immunoassay procedures to detect exposure to aflatoxin B1 and benzo[a] pyrene in animals and man at the DNA level. Int. Arch. Occup. Environ. Health 1988, 60, 145-150.
92. Chu, F. S. Immunoassay for mycotoxins, current state of the art, commercial and epidemiological applications. Vet. Human Toxicol. 1990, Suppl., 32, 42-50.
93. Chu, F. S. Recent progress on analytical techniques for mycotoxins in feedstuffs. J. Anim. Sci. 1992, 70, 3950-3963.
94. Chu, F. S. Development of antibodies against aflatoxins. In The Toxicology of Aflatoxins: Human Health, Veterinary and AgriculturalSsignificance; Eaton, D. L.; Groopman, J. D., Eds.; Academic Press: San Diego, CA, 1993; pp 451-490.
95. Chu, F. S.; Lee, R. C.; Trucksess, M. W.; Park, D. L. Evaluation of enzyme-linked immunosorbent assay of cleanup for thin-layer chromatography of aflatoxin B1 in corn, peanuts and peanut butter. J. Assoc. Off. Anal. Chem. 1988, 71, 953-956.
96. Vidyasagar, T.; Sujatha, N.; Sashidhar, R. B. Determination of AFB1-DNA adduct in rat liver by enzyme immunoassay. Analyst 1997, 122, 609-613.
97. Nayak, S.; Sashidhar, R. B.; Bhat, R. V. Quantification and validation of enzyme immunoassay for urinary AFB1-N7-guanine adduct for biological monitoring of AFs. Analyst 2001, 126, 179-183.
98. Santella, R. M.; Zhang, Y. J.; Chen, C. J.; Hsieh, L. L.; Lee, C. S.; Haghighi, B.; Yang, G. Y.; Wang, L. W.; Feitelson, M. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Environ. Health Perspect. 1993, 99, 199-202.
99. Phillips, J. C.; Davies, S.; Lake, B. G. Dose-response relationships for hepatic aflatoxin B1-DNA adduct formation in the rat in vivo and in vitro: the use of immunoslot blotting for adduct quantitation. Teratog. Carcinog. Mutagen. 1999, 19, 157-l70
100. Zhang,Y. J.; Chen, C. J.; Haghighi, B.; Yang, G. Y.; Hsieh, L. L.; Wang, L. W.; Santella, R. M. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Cancer Res. 1991, 51, 1720-1725.
101. Mandal, S.; Ahuja, A.; Shivapurkar, N. M.; Cheng, S. J.; Groopman, J. D.; Stoner, G. D. Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Carcinogenesis 1987, 8, 1651-1656
102. Pier, A. C. Aflatoxicosis and immunosuppression in mammalian animals. In AF in Maize: A Proceedings of the Workshop; Zuber, M. S.; Lillehoj, E. B.; Renfro, B. L., Eds.; CIMMYT, UNDP and USAID: Mexico, D.F. 1987; pp 58-65.
103. Niranjan, B. G.; Schaefer, H.; Ritter, C.; Avadhani, N. G. Protection of mitochondrial genetic system against AFB1 binding in animals resistant to aflatoxicosis. Cancer Res. 1986, 46, 3637-3641.
104. Barraud, L.; Douki, T.; Guerret, S.; Chevallier, M.; Jamard, C.; Trepo, C.; Wild, C. P.; Cadet, J.; Cova, L. The role of duck hepatitis B virus and AFB1 in the induction of oxidative stress in the liver. Cancer Detect. Prev. 2001, 25, 192-201.
105. Loury, D. N.; Hsieh, D. P. Effects of chronic exposure to AFB1 and AFM1 on the in vivo covalent binding of AFB1 to hepatic macromolecules. J. Toxicol. Environ. Health 1984, 13, 575-587.
106. Urban, J. D.; Clarke, W. P.; von Zastrow, M.; Nichols, D. E.; Kobilka, B.; Weinstein, H.; Javitch, J. A.; Roth, B. L.; Christopoulos, A.; Sexton, P. M.; Miller, K. J.; Spedding, M.; Mailman, R. B. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 2007, 320, 1-13.
107. Takahashi, N.; Harttig, U.; Williams, D. E.; Bailey, G. S. The model Ahreceptor agonist β-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes. Carcinogenesis 1996, 17, 79-87.
108. Stresser, D. M.; Williams, D. E.; McLellan, L. I.; Harris, T. M.; Bailey, G. S. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward AFB1 exo-epoxide. Association with reduced levels of hepatic AF-DNA adducts in vivo. Drug Metab. Dispos. 1994, 22, 392-399.
109. Im, S. H.; Bolt, M. W.; Stewart, R. K.; Massey, T. E. Modulation of AFB1 transformation by beta-naphthoflavone in isolated rabbit lung cells. Arch. Toxicol. 1996, 71, 72-79.
110. Pelkonen, P.; Lang, M.; Wild, C. P.; Negishi, M.; Juvonen, R. O. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells. Eur. J. Pharmacol. 1994, 292, 67-73.
111. Pelkonen, P.; Lang, M. A.; Negishi, M.; Wild, C. P.; Juvonen, R. O. Interaction of AFB1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity. Chem. Res. Toxicol. 1997, 10, 85-90.
112. Knight, L. P.; Primiano, T.; Groopman, J. D.; Kensler, T. W.; Sutter, T. R. cDNA cloning, expression and activity of a second human AFB1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis 1999, 20, 1215-1223.
113. Hayes, J. D.; Judah, D. J.; Neal, G. E. Resistance to AFB1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res. 1993, 53, 3887-3894.
114. Tamimi, R. M.; Lagiou, P.; Adami, H. O.; Trichopoulos, D. Prospects for chemoprevention of cancer. J. Intern. Med. 2002, 251, 286-300.
115. Egner, P. A.; De Matos, P.; Groopman, J. D.; Kensler, T. W. Effect of 1,2-dithiole-3-Thione, a monofunctional enzyme inducer, on aflatoxin-DNA adduct formation in rat liver. Proceedings -Annual Meeting of the American Association for Cancer Research, 1990, 31, p 119.
116. Allameh, A. Comparison of the effect of low-And high-dose dietary butylated hydroxytoluene on microsome-mediated aflatoxin B1-DNA binding. Cancer Lett. 1997, 114, 217-220.
117. Salocks, C. B.; Hsieh, D. P.; Byard, J. L. Effects of butylated hydroxytoluene pretreatment on the metabolism and genotoxicity of AFB1 in primary cultures of adult rat hepatocytes: selective reduction of nucleic acid binding. Toxicol. Appl. Pharmacol. 1984, 76, 498-509.
118. Shi, C. Y.; Chua, S. C.; Lee, H. P.; Ong, C. N. Inhibition of AF B1-DNA binding and adduct formation by selenium in rats. Cancer Lett. 1994, 29, 203-208.
119. Benson, A. B. Oltipraz: a laboratory and clinical review. J. Cell. Biochem., Suppl. 1993, 17F, 278-291.
120. Bolton, M. G.; Munoz, A.; Jacobson, L. P.; Groopman, J. D.; Maxuitenko, Y. Y.; Roebuck, B. D.; Kensler, T. W. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res. 1993, 53, 3499-3504.
121. O'Dwyer, P. J.; Szarka, C. E.; Yao, K. S.; Halbherr, T. C.; Pfeiffer, G. R.; Green, F.; Gallo, J. M.; Brennan, J.; Frucht, H.; Goosenberg, E. B.; Hamilton, T. C.; Litwin, S.; Balshem, A. M.; Engstrom, P. F.; Clapper, M. L. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Investig. 1996, 98, 1210-1217.
122. Kensler, T. W.; Chen, J. G.; Egner, P. A.; Fahey, J. W.; Jacobson, L. P.; Stephenson, K. K.; Ye, L.; Coady, J. L.; Wang, J. B.; Wu, Y.; Sun, Y.; Zhang, Q. N.; Zhang, B. C.; Zhu, Y. R.; Qian, G. S.; Carmella, S. G.; Hecht, S. S.; Benning, L.; Gange, S.J.; Groopman, J. D.; Talalay, P. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol. Biomark. Prev. 2005, 14, 2605-2613.
123. Kensler, T. W. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect. 1997, 105 Suppl, 965-970.
124. Kelly, V. P.; Ellis, E. M.; Manson, M. M.; Chanas, S. A.; Moffat, G. J.; McLeod, R.; Judah, D. J.; Neal, G. E.; Hayes, J. D. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-Aldehyde reductase, the glutathione Stransferase A5 and P1 subunits, and NAD H:quinone oxidoreductase in rat liver. Cancer Res. 2000, 60, 957-969.
125. Cavin, C.; Holzhauser, D.; Constable, A.; Huggett, A. C.; Schilter, B. The coffee-specific diterpenes cafestol and kahweol protect against AFB1-induced genotoxicity through a dual mechanism. Carcinogenesis 1998, 19, 1369-1375.
126. Yates, M. S.; Kwak, M. K.; Egner, P. A.; Groopman, J. D.; Bodreddigari, S.; Sutter, T. R.; Baumgartner, K. J.; Roebuck, B. D.; Liby, K. T.; Yore, M. M.; Honda, T.; Gribble, G. W.; Sporn, M. B.; Kensler, T. W. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid [2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole. Cancer Res. 2006, 66, 2488-2494.
127. Elegbede, J. A.; Gould, M. N. Monoterpenes reduced adducts formation in rats exposed to aflatoxin B1. African J. Biotech. Acad J., Nairobi, Kenya 2002, 1, 46-49.
128. Miyata, M.; Takano, H.; Guo, L. Q.; Nagata, K.;Yamazoe, Y. Grapefruit juice intake does not enhance but rather protects against AFB1-induced liver DNA damage through a reduction in hepatic CYP3A activity. Carcinogenesis 2004, 25, 203-209.
129. Netke, S. P.; Roomi, M. W.; Tsao, C.; Niedzwiecki, A. Ascorbic acid protects guinea pigs from acute aflatoxin toxicity. Toxicol. Appl. Pharmacol, 1997, 143, 429-435.
130. Wong, B. Y.; Lau, B. H.; Yamasaki, T.; Teel, R. W. Inhibition of dexamethasone-induced cytochrome P450-mediated mutagenicity and metabolism of AFB1 by Chinese medicinal herbs. Eur. J. Cancer Prev. 1993, 2, 351-356.
131. Egner, P. A.; Wang, J. B.; Zhu, Y. R.; Zhang, B. C.; Wu, Y.; Zhang, Q. N.; Qian, G. S.; Luang, S. Y.; Gange, S. J.; Jacobson, L. P.; Helzlsouer, K. J.; Bailey, G. S.; Groopman, J. D.; Kensler, T. W. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 14601-14606.
132. El-Nezami, H. S.; Polychronaki, N. N.; Ma Ping, Z.; HuiLian, L.; WenHua, S. E. K.; Juvonen, R. O.; Salminen, S. J.; Poussa, T.; Mykkanen, H. M. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Amer. J. Clin. Nutr. 2006, 83, 1199-1203.
133. Reddy, L.; Odhav, B.; Bhoola, K. Aflatoxin B1-induced toxicity in HepG2 cells inhibited by carotenoids: morphology, apoptosis and DNA damage. Biol Chem. 2006, 387, 87-93.